litlas
Log inCreate account

Ed Harlow

Active 1980–2011

70
Papers
28,737
Citations
70
h-index
70
i10-index

Citations

Citations per year for Ed Harlow1975: 1 citations1981: 14 citations1982: 17 citations1983: 16 citations1984: 29 citations1985: 32 citations1986: 44 citations1987: 27 citations1988: 59 citations1989: 162 citations1990: 271 citations1991: 355 citations1992: 414 citations1993: 597 citations1994: 507 citations1995: 533 citations1996: 568 citations1997: 480 citations1998: 426 citations1999: 448 citations2000: 451 citations2001: 454 citations2002: 448 citations2003: 358 citations2004: 352 citations2005: 305 citations2006: 261 citations2007: 204 citations2008: 196 citations2009: 208 citations2010: 163 citations2011: 159 citations2012: 160 citations2013: 131 citations2014: 114 citations2015: 99 citations2016: 82 citations2017: 99 citations2018: 71 citations2019: 245 citations2020: 229 citations2021: 178 citations2022: 152 citations2023: 91 citations2024: 116 citations2025: 60 citations2026: 1 citations1976–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,044 citing papers, 47% of this breakdownUnited Kingdom: 661 citing papers, 7.7% of this breakdownGermany: 476 citing papers, 5.5% of this breakdownChina: 350 citing papers, 4.1% of this breakdownCanada: 348 citing papers, 4% of this breakdownJapan: 322 citing papers, 3.7% of this breakdownFrance: 305 citing papers, 3.6% of this breakdownItaly: 198 citing papers, 2.3% of this breakdownAustralia: 157 citing papers, 1.8% of this breakdownNetherlands: 137 citing papers, 1.6% of this breakdownSwitzerland: 133 citing papers, 1.6% of this breakdownSpain: 131 citing papers, 1.5% of this breakdown
0%47%Other 15.6%

Institutions

Fields

  • Medicine48.3%
  • Biochemistry, Genetics and Molecular Biology44.6%
  • Immunology and Microbiology2.2%
  • Neuroscience2%
  • Agricultural and Biological Sciences1.1%
  • Chemistry0.4%
  • Other1.4%

Topics

  • Cancer-related Molecular Pathways12.9%
  • Microtubule and mitosis dynamics3.9%
  • Virus-based gene therapy research3.8%
  • Ubiquitin and proteasome pathways3.7%
  • Epigenetics and DNA Methylation3.6%
  • Genomics and Chromatin Dynamics2.6%
  • Other69.5%

Coauthors

All papers

Open in search
  1. The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product

    Authors: Nicholas J. Dyson, Peter M. Howley, Karl Münger, Ed Harlow - Science 1989 cited by 3,067

  2. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

    Authors: Diane C. Fingar, Sofie R. Salama, Christina Tsou, Ed Harlow, John Blenis - Genes & Development 2002 cited by 1,097

  3. The retinoblastoma tumour suppressor in development and cancer

    Authors: Marie Classon, Ed Harlow - Nature reviews. Cancer 2002 cited by 742

  4. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5

    Authors: Li‐Huei Tsai, Ivana Delalle, Verne S. Caviness, Teresa H. Chae, Ed Harlow - Nature 1994 cited by 928

  5. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A

    Authors: Brenda A. Schulman, Derek L. Lindstrom, Ed Harlow - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 383

  6. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

    Authors: Matthew Meyerson, Ed Harlow - Molecular and Cellular Biology 1994 cited by 799

  7. NPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcription

    Authors: Jiyong Zhao, Brian K. Kennedy, Brandon D. Lawrence, David A. Barbie, A. Gregory Matera, Jonathan A. Fletcher, Ed Harlow - Genes & Development 2000 cited by 670

  8. Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control

    Authors: Sander van den Heuvel, Ed Harlow - Science 1993 cited by 1,099

  9. Identification of G1 Kinase Activity for cdk6, a Novel Cyclin D Partner

    Authors: Matthew Meyerson, Ed Harlow - Molecular and Cellular Biology 1994 cited by 224

  10. Differential regulation of E2F transactivation by cyclin/cdk2 complexes.

    Authors: Brian David Dynlacht, Osvaldo Flores, Jacqueline A. Lees, Ed Harlow - Genes & Development 1994 cited by 396

  11. A family of human cdc2‐related protein kinases.

    Authors: Matthew Meyerson, G H Enders, Chia‐Ling Wu, Li Su, Claude Gorka, C. Nelson, Ed Harlow, Li‐Huei Tsai - The EMBO Journal 1992 cited by 921

  12. Cellular targets for transformation by the adenovirus E1A proteins

    Authors: Peter Whyte, Nicola M. Williamson, Ed Harlow - Cell 1989 cited by 754

  13. Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1

    Authors: Lili Yamasaki, Tyler Jacks, Roderick T. Bronson, Evelyne Goillot, Ed Harlow, Nicholas J. Dyson - Cell 1996 cited by 705

  14. A kinase shRNA screen links LATS2 and the pRB tumor suppressor

    Authors: Katrin Tschöp, Andrew R. Conery, Larisa Litovchick, James A. DeCaprio, Jeffrey Settleman, Ed Harlow, Nicholas J. Dyson - Genes & Development 2011 cited by 124

  15. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

    Authors: Peter Whyte, Karen Buchkovich, Jonathan M. Horowitz, Stephen Friend, Margaret Raybuck, Robert A. Weinberg, Ed Harlow - Nature 1988 cited by 1,436

  16. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products

    Authors: Ed Harlow, B. Robert Franza, Carol Schley - Journal of Virology 1985 cited by 399

  17. Key Roles for E2F1 in Signaling p53-Dependent Apoptosis and in Cell Division within Developing Tumors

    Authors: Huichin Pan, Chaoying Yin, Nicholas J. Dyson, Ed Harlow, Lili Yamasaki, Terry Van Dyke - Molecular Cell 1998 cited by 192

  18. Kinase requirements in human cells: III. Altered kinase requirements in VHL −/− cancer cells detected in a pilot synthetic lethal screen

    Authors: Archana Bommi‐Reddy, Ingrid Almeciga, J. Scott Sawyer, Christoph Geisen, Wenliang Li, Ed Harlow, William G. Kaelin, Dorre A. Grueneberg - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 141

  19. Expression of Dominant-Negative Mutant DP-1 Blocks Cell Cycle Progression in G 1

    Authors: Chin‐Lee Wu, Marie Classon, Nicholas J. Dyson, Ed Harlow - Molecular and Cellular Biology 1996 cited by 138

  20. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

    Authors: Karen Buchkovich, Linda Duffy, Ed Harlow - Cell 1989 cited by 1,027

  21. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system

    Authors: Li‐Huei Tsai, Takao Takahashi, Verne S. Caviness, Ed Harlow - Development 1993 cited by 454

  22. The retinoblastoma protein binds to a family of E2F transcription factors.

    Authors: Jacqueline A. Lees, Midori Saito, Marc Vidal, Marcus Valentine, Thomas Look, Ed Harlow, Nicholas J. Dyson, Kristian Helin - Molecular and Cellular Biology 1993 cited by 436

  23. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation

    Authors: Brett Johnson, Ryan T. Nitta, Richard L. Frock, Leslie C. Mounkes, David A. Barbie, Colin L. Stewart, Ed Harlow, Brian K. Kennedy - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 282

  24. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice

    Authors: Lili Yamasaki, Roderick T. Bronson, Bart O. Williams, Nicholas J. Dyson, Ed Harlow, Tyler Jacks - Nature Genetics 1998 cited by 280